Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RHEB pseudogene 2 is a transcribed sequences that shares sequence homology with the RHEB gene but does not encode a functional GTPase or any other active protein. RHEB itself is a small GTPase involved in the regulation of the mTOR pathway and cell growth, but its pseudogenes, including RHEB pseudogene 2, do not have an established biological or pharmacological function[1][3][5]. There are at least three known RHEB pseudogenes in the human genome (two on chromosome 10, one on chromosome 22), but current evidence supports that these do not contribute to protein signaling or serve as therapeutic targets[1][3]. If you are seeking information on a therapeutic target, you likely want the protein-coding RHEB gene, not this pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RHEB pseudogene 2 (RHEBP2).